Leishmania major. A clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone

Experimental Parasitology

Volumn 87, Issue 1, 1997, Pages 47-57

  Li, Jian ^a   Nolan, Thomas J ^a   Farrell, Jay P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clone; FBS, fetal bovine serum; IFN interferon gamma; IL, interleukin; Immunity; Leishmania major; Th, T helper; Virulence

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL;

ANIMALIA; BOVINAE; LEISHMANIA MAJOR;

EID: 0031239580     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4183     Document Type: Article

References (39)

1. Afonso, L. C. C., and Scott, P. 1994. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infection and Immunity 61, 2952-2959.
2. Almeida, R. P., Barral-Netto, M., De Jesus, A. M. R., De Freitas, L. A. R., Carvalho, E. M., and Barral, A. 1996. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice. American Journal of Tropical Medicine and Hygiene 54, 178-184.
3. Behforouz, N. C., Wenger, C. D., and Mathison, B. A. 1986. Prophylactic treatment of BALB/c mice with cyclosporin A and its analog, B-5-49 enhances resistance to Leishmania major. The Journal of Immunology 136, 3067-3075.
4. Bretscher, P. A., Wei, G., Menon, J. N., and Bielefeldt-Ohmann, H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257, 539-542.
5. Chatelain, R., Varkila, K., and Coffman, R. L. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. The Journal of Immunology 148, 1182-1187.
6. Curry, R. C., Kiener, P. A., and Spitalny, G. L. 1987. A sensitive immunochemical assay for biologically active MuIFN-gamma. The Journal of Immunological Methods 104, 137-142.
7. Detolla, L. J., Jr., Scott, P. A., and Farrell, J. P. 1981. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics 14, 29-39.
8. Engel, J. C., Doyle, P. S., and Dvorak, J. A. 1985. Trypanosoma cruzi: Biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle. Journal of Protozoology 32, 80-83.
9. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R., and Paul, W. E. 1990. Lymphokine regulation of in vivo immunoglobulin isotype selection. Annual Review of Immunology 8, 303-333.
10. Gazzinelli, R. T., Heiny, S., Wynn, T. A., Wolf, S., and Sher, A. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proceedings of the National Academy of Science USA 90, 6115-6119.
11. Gorczynski, R. M. 1985. Immunization of susceptible BALB/c mice against Leishmania braziliensis. Cellular Immunology, 94:11-20.
12. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Science USA 88, 7011-7015.
13. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., and Gately, M. K. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. The Journal of Experimental Medicine 177, 1505-1509.
14. Howard, J. G., Hale, C., and Chan-Liew, W. L. 1980. Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunology 2, 303-314.
15. Howard, J. G., Liew, F. Y., Hale, C., and Nicklin, S. 1984. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. The Journal of Immunology 132, 450-455.
16. Kellina, O. I. 1965. A comparative study of the virulence of Leishmania tropica major strains, (in Russian). Meditsinskaia Parazitologiia I Parasitarnye Bolezni 34, 309-317.
17. Kreutzer, R. D., Souraty, N., and Semko, M. E. 1987. Biochemical identities and differences among Leishmania species and subspecies. American Journal of Tropical Medicine and Hygiene 36, 22-32.
18. Marchand, M., Daoud, S., Titus, R. G., Louis, J., and Boon, T. 1987. Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunology 9, 81-92.
19. McGurn, M., Boon, T., Louis, J. A., and Titus, R. G. 1990. Leishmania major: Nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice. Experimental Parasitology 71, 81-89.
20. Mitchell, G. F., Handman, E., and Spithill, T. W. 1984. Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection. Australian Journal of Experimental Biology & Medical Science 62, 145-153.
21. Mitchell, G. F., Handman, E., and Spithill, T. W. 1985. Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major. International Journal for Parasitology 15, 677-684.
22. Monroy-Ostria, A., Fuentes-Fraga, I., Garcia-Flores, C., and Favila-Castillo, L. 1994. Infection of BALB/c, C57B1/6 mice and F1 hybrid CB6F1 mice with strains of Leishmania mexicana isolated from Mexican patients with localized or diffuse cutaneous leishmaniasis. Archives of Medical Research 25, 401-406.
23. Nabors, G. S., Afonso, L. C. C., Farrell, J. P., and Scott, P. 1994. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proceedings of the National Academy of Science USA 92, 3142-3146.
24. Nabors, G. S., and Farrell, J. P. 1994a. Site-specific immunity to Leishmania major in SWR mice: The site of infection influences susceptibility and the expression of the antileishmanial immune response. Infection and Immunity 62, 3655-3662.
25. Nabors, G. S., and Farrell, J. P. 1994b. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infection and Immunity 62, 5498-5504.
26. Nabors, G. S., and Farrell, J. P. 1996. Successful chemotherapy of experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. Journal of Infectious Diseases 173, 979-986.
27. Nabors, G. S., Nolan, T., Croop, W., Li, J., and Farrell, J. P. 1995. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c × C57BL/6) F1 mice infected with Leishmania major. Parasite Immunology 17, 569-579.
28. Postan, M., McDaniel, J. P., and Dvorak, J. A. 1986. Trypanosoma cruzi: Constancy of clone pathogenicity for inbred mice during long-term in vitro maintenance. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 659-662.
29. Reiner, S. L., and Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annual Review of Immunology 13, 151-177.
30. Sacks, D. L., Heiny, S., and Sher, A. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. The Journal of Immunology 135, 564-569.
31. Sadick, M. D., Heinzel, F.P., Holaday, B. J., Pu, R. T., Dawkins, R. S., and Locksley, R. M. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, Interferon gamma-independent mechanism. The Journal of Experimental Medicine 171, 115-125.
32. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G., and Scott, P. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. The Journal of Immunology 154, 5320-5330.
33. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. The Journal of Immunology 147, 3149-3155.
34. Scott, P., Natovitz, P., Coffman, R. L., Pearce, E., and Sher, A. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. The Journal of Experimental Medicine 168, 1675-1684.
35. Scott, P., Pearce, E., Natovitz, P., and Sher, A. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. The Journal of Immunology 139, 221-227.
36. Segovia, M., Artero, J. M., Mellado, E., and Chance, M. L. 1992. Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes. Annals of Tropical Medicine and Parasitology 86, 347-354.
37. Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., and Schaub, R. G. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. The Journal of Experimental Medicine 177, 1797-1802.
38. Titus, R. G., Gueiros-Filho, F. J., De Freitas, L. A., and Beverley, S. M. 1995. Development of a safe live Leishmania vaccine line by gene replacement. Proceedings of the National Academy of Science USA 92, 10267-10271.
39. Wynn, T. A., Eltoum, I., Cheever, A. W., Lewis, F. A., Gause, W. C., and Sher, A. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. The Journal of Immunology 151, 1430-1440.